Health experts agree that a vaccine is key to fighting the COVID-19 global pandemic and restoring life and the economy to what it was. The fastest vaccine ever developed in human history took four years, but the community of universities and biotechnology companies feel confident that through global collaboration a COVID-19 vaccine can be ready in 18 months. The race is on. The WHO published a list of 76 vaccine candidates on 20 April and this is now the official list. We have no knowledge of which company will win the race to find a vaccine against COVID-19. But we have found all the companies with Saxo ticker codes, so that it’s easier for you to identify the companies that can offer you exposure to this potential upside. It's important to recognise that investing in this opportunity comes with very high risk as some of the companies are illiquid and have small market values. But in general the risks of developing a vaccine are high, as you are competing against many other companies and universities. More importantly a vaccine is not just a vaccine as each comes with different coverage ratio of the various mutations but also with different risk profiles for the various age cohorts.
Companies on the WHO vaccine list, which you can trade via SaxoTraderGO, ordered by market cap.
|600196:xssc||Shanghai Fosun Pharmaceutical||28.5||11685|
|APDN:xnas||Takara Bio Inc||23.0||2860|
|INO:xnas||Inovio Pharmaceuticals Inc||205.5||1471|
|ARCT:xnas||Arcturus Therapeutics Holdings||272.2||804|
|DVAX:xnas||Dynavax Technologies Corp||-29.2||355|
|HTBX:xnas||Heat Biologics Inc||15.1||45|
|IPA:xtsx||ImmunoPrecise Antibodies Ltd||32.8||38|
|EXPRS2:xome||Expres2ion Biotech Holding AB||380.7||30|
For more coronavirus trading inspiration, check the coronavirus section in SaxoTraderGO.